ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,918.80
      -2.26%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.61
      -0.33%
      Bitcoin
      60,256.37
      -0.57%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ATAI Life Sciences NV (ATAI)

      7. ATAI Life Sciences NV (ATAI) News

      ATAI

      ATAI Life Sciences NV (ATAI)

      ATAI Life Sciences NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATAI
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      04/24/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
      04/17/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of PsychopharmacologyNASDAQ:ATAIATAI Life Sciences NV
      03/28/20247:00AMGlobeNewswire Inc.atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical HighlightsNASDAQ:ATAIATAI Life Sciences NV
      03/27/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
      03/04/20248:00AMGlobeNewswire Inc.atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01NASDAQ:ATAIATAI Life Sciences NV
      02/28/20245:00PMGlobeNewswire Inc.atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care ConferenceNASDAQ:ATAIATAI Life Sciences NV
      02/13/20244:29PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATAIATAI Life Sciences NV
      02/06/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      02/06/20245:00PMGlobeNewswire Inc.atai Life Sciences Appoints Anne Johnson as Chief Financial OfficerNASDAQ:ATAIATAI Life Sciences NV
      01/23/20247:46AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      01/09/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
      01/09/20244:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      01/04/20248:53AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      01/04/20247:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      01/04/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration PsychedelicsNASDAQ:ATAIATAI Life Sciences NV
      01/02/20248:00AMGlobeNewswire Inc.atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)NASDAQ:ATAIATAI Life Sciences NV
      11/20/20239:17AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
      11/14/20237:03AMGlobeNewswire Inc.atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline HighlightsNASDAQ:ATAIATAI Life Sciences NV
      10/13/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      10/10/20238:00AMPR Newswire (Canada)ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORTNASDAQ:ATAIATAI Life Sciences NV
      10/06/20234:05PMGlobeNewswire Inc.atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro SummitNASDAQ:ATAIATAI Life Sciences NV
      10/02/20234:13PMGlobeNewswire Inc.atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy ParticipantsNASDAQ:ATAIATAI Life Sciences NV
      09/29/20234:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      09/14/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
      09/14/20238:02AMGlobeNewswire Inc.atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:ATAIATAI Life Sciences NV
      09/06/20234:01PMGlobeNewswire Inc.atai Life Sciences to Participate in Upcoming September Investor ConferencesNASDAQ:ATAIATAI Life Sciences NV
      08/31/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
      08/10/20234:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATAIATAI Life Sciences NV
      08/10/20237:42AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
       Showing the most relevant articles for your search:NASDAQ:ATAI